Nicholas Ambulos is the director of the Biopolymer/Genomics Core Facility at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, having an extensive background in molecular biology and molecular microbiology. He is fully familiar with all aspects of DNA and RNA synthesis, DNA sequencing, genotyping, peptide synthesis and more recently has become exceedingly familiar with gene expression technologies.

He is responsible for introducing new investigators to the facility, by providing detailed descriptions of the services offered and introducing investigators to the staff members responsible for these services. After initial consultations regarding specific projects, the investigators are encouraged to interact directly with the staff members that will be supporting their research projects. He is also responsible for the educational component of the core, arranging to host research and technical seminars, as well as presenting the Facility’s capabilities at Departmental meetings.

Nicholas Ambulos has been successful in securing NIH Shared Instrumentation Grants with which he purchased new instrumentation. He has also taken advantage of the State of Maryland’s Revolving Equipment Loan Program, whereby the State purchases an instrument for the facility and the facility repays the loan with modest interest.

The Greek researcher has also served as the Director of Shared Services for the Marlene and Stewart Greenebaum Cancer Center. In this role, he provided guidance to other shared service directors to ensure that the services offered are effective and strengthen the mission of the Greenebaum Comprehensive Cancer Center.

Nicholas Ambulos has co-authored a number of manuscripts relating to peptide synthesis chemistry and analysis and was responsible for the synthesis and purification of the three peptides that comprise the reference material “Peptide Standards for Molecular Mass and Purity Measurements”.